IL-6 Receptor anticorps (AA 192-458)

N° du produit ABIN2624209

Cet anticorps anti-IL-6 Receptor est un anticorps Lapin Polyclonal détectant IL-6 Receptor dans WB. Adapté pour Humain.

Aperçu rapide pour IL-6 Receptor anticorps (AA 192-458) (ABIN2624209)

Antigène: IL-6 Receptor (IL6R) (Interleukin 6 Receptor (IL6R))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IL-6 Receptor est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-IL-6 Receptor anticorps

Épitope: AA 192-458

Specificité: Human IL6R / IL6 Receptor

Purification: Immunoaffinity purified

Immunogène: Recombinant fragment corresponding to a region within amino acids 192 and 458 of IL6 Receptor (SwissProt P08887). Percent identity by BLAST analysis: Human (100%).

Type of Immunogen: Recombinant protein

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7, 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid multiple freeze-thaw cycles.

Stock: -20 °C

Stockage commentaire: Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Détails sur IL-6 Receptor

Antigène: IL-6 Receptor (IL6R) (Interleukin 6 Receptor (IL6R))

Autre désignation: IL6R / IL6 Receptor

Sujet: Name/Gene ID: IL6R
Family: Interleukin

Synonyms: IL6R, CD126, gp80, IL-6R subunit alpha, IL-6R-alpha, IL-6RA, IL6Q, IL-6 receptor subunit alpha, IL-6R 1, IL-6R-1, Interleukin 6 receptor, Membrane glycoprotein 80, CD126 antigen, IL6RA, IL6RQ

ID gène: 3570

Pathways: Signalistation JAK/STAT, Autophagy, Growth Factor Binding, Cancer Immune Checkpoints